Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
ECN Capital Corp
T.ECN
Alternate Symbol(s):
ECNCF
|
ECNNF
|
T.ECN.PR.C
|
T.ECN.DB.A
|
T.ECN.DB.B
|
T.ECN.DB.C
Financial Services
Asset Management
ECN Capital Corp. is a Canada-based company. The Company is a provider of business services to North American banks, credit unions, life insurance companies, pension funds and institutional investors (collectively, its Partners). It originates, manages and advises on credit assets on behalf of its Partners, specifically consumer (manufactured housing and recreational vehicle and marine) loans...
and commercial (inventory finance or floorplan) loans. The Company operates through two segments: Manufactured Housing Finance, and Recreational Vehicles (RV) and Marine Finance. Its business segment includes Triad Financial Services, Source One Financial, and Intercoastal Finance Group. The Triad Financial Services is a portfolio solutions platform focused on originating and managing longer duration secured consumer loan portfolios for active partner. The Source One Financial originates prime and super-prime loans to consumers to facilitate the purchase of recreational and marine vehicles.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:ECN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(15)
•••
Blueswin
X
Post by
Blueswin
on May 09, 2025 4:01pm
CIBC $3.5 hold
09 May 2025 ECN CIBC Nik Priebe 393 HOLD $3.50
(15)
•••
Blueswin
X
Post by
Blueswin
on May 08, 2025 9:42pm
Looks like a positive Q1!
Reaffirming 2025 consolidated guidance of $0.19 to $0.25
(202)
•••
TeamCommonSense
X
Post by
TeamCommonSense
on Apr 10, 2025 1:03pm
From TD:
ECN Capital Corp. (ECN-T) On April 3 and 4, chief executive officer and director Steve Hudson invested more than $1.5-million in shares of ECN Capital. He acquired a total of 600,000 shares at
...more
(17)
•••
CarlM20
X
Comment by
CarlM20
on Apr 10, 2025 7:52am
RE:Drop in preferred share price yesterday ...
I have some of those prefered and like them a lot. My guess is that there is a possibility they get called at the next reset date. Around 20$ is great value.
(1776)
•••
Possibleidiot01
X
Post by
Possibleidiot01
on Apr 08, 2025 5:18pm
insider buy from marketbeat.com
ECN Capital Corp. (TSE:ECN - Get Free Report) Director Steven Kenneth Hudson purchased 200,000 shares of ECN Capital stock in a transaction on Friday, April 4th. The stock was bought at an average
...more
(202)
•••
TeamCommonSense
X
Post by
TeamCommonSense
on Apr 01, 2025 1:46pm
Drop in preferred share price yesterday ...
... anybody with some insight as to what happened? All I can see is that TD dumped a bunch of shares indiscriminately and ... as can happen with thinly traded shares ... the price collapsed. I got
...more
(15)
•••
Blueswin
X
Post by
Blueswin
on Feb 27, 2025 5:27pm
ECN Capital Reports US$0.02 in Adjusted Net Income 4Q
Results don't look great Because the had weather problems in being able to deliver some MH.
(202)
•••
TeamCommonSense
X
Post by
TeamCommonSense
on Feb 05, 2025 11:28am
Analyst update
National Bank analyst looking at sector named Diversified Financials: The analyst reaffirmed ECN Capital Corp. (ECN-T) as his top pick for the year ahead. He has an “outperform” rating and $5
...more
(15)
•••
Blueswin
X
Post by
Blueswin
on Jan 03, 2025 1:59pm
ECN new year high
ECN hit $3.28 today & is finally headed in the right direction. Great to see!
(15)
•••
Blueswin
X
Comment by
Blueswin
on Dec 16, 2024 3:55pm
RE:Analyst update National Bank
Thank you for posting this! This is all very encouraging!
(202)
•••
TeamCommonSense
X
Post by
TeamCommonSense
on Dec 16, 2024 11:33am
Analyst update National Bank
Expecting a “strong” year for ECN Capital Corp. (ECN-T), National Bank Financial analyst Jaeme Gloyn named it his top pick for 2025. In a research note released before the bell, he pointed
...more
(15)
•••
Blueswin
X
Post by
Blueswin
on Dec 16, 2024 11:25am
Good move today!
Has not been this high since May 1st 2023. Any ideas on why the jump in the share price?
(17)
•••
CarlM20
X
Comment by
CarlM20
on Dec 05, 2024 8:03am
RE:RE:ECN.PR.C
Salut, I have many preferred C. My bet is a redemption at $25. Happy to see I am not alone investing in the prefered C. Recent boost is fantastic. The minimum rate reset is also nice. Good
...more
(290)
•••
pierrelebel
X
Comment by
pierrelebel
on Nov 22, 2024 6:21pm
RE:ECN.PR.C
Two weeks later and the price of ECN.PR.C keeps going up. $2.00 in two weeks to $22.00. Not bad at all. Yet, the preferred shares are still attractive at this price yielding a bit more than 9% (tax
...more
(202)
•••
TeamCommonSense
X
Post by
TeamCommonSense
on Nov 12, 2024 12:02pm
Analyst update
ECN Capital Corp. (ECN-T): Cormark Securities raises PT to C$3.50 from C$2.25
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers